Production (Stage)
Biohaven Ltd.
BHVN
$15.06
-$0.28-1.83%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 51.29% | 9.23% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 23.76% | 0.48% | |||
| Operating Income | -23.76% | -0.48% | |||
| Income Before Tax | -18.35% | -16.48% | |||
| Income Tax Expenses | 1,168.75% | 181.36% | |||
| Earnings from Continuing Operations | -18.64% | -16.56% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -18.64% | -16.56% | |||
| EBIT | -23.76% | -0.48% | |||
| EBITDA | -24.21% | -0.22% | |||
| EPS Basic | -17.61% | -8.85% | |||
| Normalized Basic EPS | -22.58% | -2.48% | |||
| EPS Diluted | -17.61% | -8.85% | |||
| Normalized Diluted EPS | -22.58% | -2.48% | |||
| Average Basic Shares Outstanding | 0.88% | 7.08% | |||
| Average Diluted Shares Outstanding | 0.88% | 7.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||